Publications & Works

Publication Network
Articles 11
All (11)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (11)
Scopus (11)
TRDizin (2)

1. Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study

Hacan B. A., SONUGÜR F. G., Öçal M., BABAHAN SUİÇMEZ C., Abgarmi S., Arslan Ü. Y., et al.
International Journal of Cancer , 2026 (SCI-Expanded, Scopus)

2. Protective Effects of SIRT2 Inhibition on Cardiac Fibrosis

AKBULUT KOYUNCU İ. M., Aktan A. K., SONUGÜR F. G., Akarca S. Ö., BAHAR A. N., Kavak H., et al.
Anatolian Journal of Cardiology , vol.29, no.4, pp.173-180, 2025 (SCI-Expanded, Scopus, TRDizin)

3. AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.

BAHAR A. N., Keskin-Aktan A., Akarca-Dizakar S. Ö., Sonugür G., AKBULUT K. G.
Journal of biochemical and molecular toxicology , vol.38, no.11, 2024 (SCI-Expanded, Scopus)

4. The effects of anti-PD-L1 monoclonal antibody on the expression of angiogenesis and invasion-related genes

BABAHAN C., Abdi Abgarmi S., SONUGÜR F. G., Öçal M., AKBULUT H.
TURKISH JOURNAL OF BIOLOGY , vol.47, no.4, pp.262-275, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development

5. Incubation Temperature and Period During Denarase Treatment and Microfiltration Affect the Yield of Recombinant Adenoviral Vectors During Downstream Processing

Sonugür F. G., Babahan C., Abdi Abgarmi S., Akbulut H.
MOLECULAR BIOTECHNOLOGY , vol.65, no.7, pp.1129-1139, 2023 (SCI-Expanded, Scopus) Sustainable Development

6. Protective Effect of Pharmacological SIRT2 Inhibition on Renal Dysfunction, Fibrosis, TGF-β1/β-Catenin, and Klotho Signaling in D-Galactose-Induced Aging Model

Keskin-Aktan A., BAHAR A. N., SONUGÜR F. G., Akarca-Dizakar S. O., AKBULUT K. G.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS , no.11, pp.6061-6072, 2023 (SCI-Expanded, Scopus)

7. The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors

Sonugür F. G., Akbulut H.
FRONTIERS IN GENETICS , vol.10, 2019 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

8. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

AKBULUT H., Ocal M., Sonugur F. G., Abgarmi S. A., BABAHAN C., Akay B., et al.
JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018 (SCI-Expanded, Scopus) Sustainable Development

9. The effects of melatonin and curcumin on the expression of SIRT2, Bcl-2 and Bax in the hippocampus of adult rats

Keskin-Aktan A., Akbulut K. G., Yazici-Mutlu C., Sonugür F. G., Ocal M., Akbulut H.
BRAIN RESEARCH BULLETIN , pp.306-310, 2018 (SCI-Expanded, Scopus) Sustainable Development

10. The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)

AKBULUT H., Ocal M., Sonugur G., AKAY B. N., BABAHAN C., Abgarmi S. A., et al.
ANNALS OF ONCOLOGY , vol.27, 2016 (SCI-Expanded, Scopus) Sustainable Development

11. A novel fluorescence turn-on coumarin-pyrazolone based monomethine probe for biothiol detection

Babur B., SEFEROĞLU N., Ocal M., SONUGÜR F. G., AKBULUT H., SEFEROĞLU Z.
TETRAHEDRON , no.30, pp.4498-4502, 2016 (SCI-Expanded, Scopus) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 18

1. Kanser Görüntüleme ve Tedavisinde Kullanılabilecek Rekombinant Tek Zincirli Değişken Fragment (ScFv) Antikoru Saflaştırma Optimizasyonu

BABAHAN C., SONUGÜR F. G., AKBULUT H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024, (Summary Text)

2. Kanser Tedavisinde Kullanılan Replikasyon Defektif Adenoviral Vektörlerin Maliyn ve Beniyn Hücreler Üzerindeki Etkisi

Korgan E., Babahan C., Sonugür F. G., Abdi Abgarmi S., Akbulut H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024, pp.46, (Summary Text) Creative Commons License

3. Replikasyon Defektif Adenoviral Vektörler Tümör Hücrelerinden İmmünsüpresif Sitokin Salgısını Azaltıyor

Zengin İ., Sonugür F. G., Babahan C., Abdi Abgarmi S., Akbulut H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024, pp.47, (Summary Text) Creative Commons License

4. Kanser tedavisinde kullanılmak üzere anti_CD47 scFv gen tedavi vektörleri geliştirilmesi

SONUGÜR F. G., Korgan E., BABAHAN C., AKBULUT H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024, (Summary Text)

5. Replication Defective Adenoviral Vectors Decreases the Immunosuppresive Cytokine Expression in Tumor Cells

Zengin İ., SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 September 2023, (Summary Text)

6. Low-Dose Chemotherapy Inhibits Proangiogenic Factors in Endothelial and Cancer Cells

SONUGÜR F. G., BABAHAN C., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 - 30 September 2023, (Summary Text)

7. Replication Defective Adenoviral Vectors do not induce Apoptosis and Autophagy in endothelial cells

Korgan E., BABAHAN C., SONUGÜR F. G., Abdi Abgarmi S., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 September 2023, (Summary Text)

8. Purification Optimization Of A Recombinant Single-Chain Variable Fragment (ScFv) Antibody

BABAHAN C., SONUGÜR F. G., KARAGÖZ Z., YILMAZ E., AKBULUT H.
BIOTürkiye, İstanbul, Turkey, 28 - 30 September 2023, (Full Text)

9. Effect of SIRT2 Inhibition on Developing Fibrosis in D-GalactoseInduced Aging Model

BAHAR A. N., KESKİN AKTAN A., SONUGÜR F. G., AKARCA DİZAKAR S. Ö., AKBULUT K. G.
47th Turkish Physiology Congress, Antalya, Turkey, 05 January 2023, pp.22, (Full Text)

10. DOWNSTREAM PROSES SÜRECİNDE İNKÜBASYON SICAKLIĞI VE MİKROFİLTRASYON MEMBRANI SEÇİMİNİN REKOMBİNANT ADENOVİRAL VEKTÖR VERİMİNE ETKİSİ

SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
4.Uluslararası Aşı Bilimi Kongresi, Ankara, Turkey, 03 November 2022, vol.1, pp.1, (Full Text)

11. The Effect of PD-L1 Expression on Angiogenesis and Invasion in Tumor Cells

BABAHAN C., Abdi Abgarmi S., SONUGÜR F. G., AKBULUT H.
Immuno-Oncology 2019, Barselona, Spain, 23 May 2019, pp.6-7, (Summary Text)

12. Anti-Angiogenic Treatment Suppresses the Immunosuppressive Cytokine Production in Tumor Cells

Abdi Abgarmi S., BABAHAN C., SONUGÜR F. G., AKBULUT H.
Immuno-Oncology 2019, Barselona, Spain, 23 May 2019, (Summary Text)

13. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

AKBULUT H., Öçal M., Sonugür F. G., Babahan C., Abdi Abgarmi S.
ASCO 2018, 1 - 04 June 2018, (Summary Text) Sustainable Development

14. Effect of very low doses of chemotherapeutic drugs on proangiogenic factors in tumor cells.

Ocal M., Sonugur F. G., BABAHAN C., Abgarmi S. A., Icli F., AKBULUT H.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 06 June 2017, vol.35, (Summary Text)

15. The effects of very low doses of chemotherapeutic drugs on endothelial cells.

Sonugur F. G., Ocal M., BABAHAN C., Abgarmi S. A., Icli F., AKBULUT H.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 06 June 2017, vol.35, (Summary Text)

16. Metronomik Kemoterapinin Tümör Hücrelerinde Anjiyogenik Faktör Sentezi Üzerindeki Etkileri

ÖÇAL DEMİRTAŞ M., SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 23 April 2017, (Summary Text)

17. Metronomik Kemoterapinin Endotel Hücre Fonksiyonları Üzerindeki Etkisi

SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Full Text)

18. The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectalcancer mCRC

AKBULUT H., Öcal M., Sonugür G., AKAY B., Bahahan C., Abgarmi S. A., et al.
ESMO Congress, 7 - 11 October 2016, (Summary Text)
Books 3

1. Kanser Biyolojisi

Babahan C., Sonugür F. G., Akbulut H.
in: İç Hastalıkları, İliçin Gürler,Biberoğlu Kadir,Süleymanlar Gültekin,Ünal Serhat, Editor, Güneş Tıp Kitabevi, Ankara, pp.1659-1670, 2024

2. Viral Vektör Aşıları

Sonugür F. G., Babahan C., Akbulut H.
in: Aşı Çalışmaları ve Teknolojisi, Mert Döşkaya,Adnan Yüksel Gürüz,Ayşe Gülten Kantarcı,Cemal Ün, Editor, Nobel Tıp Kitabevi, Ankara, pp.355-382, 2023

3. Cancer Gene Therapy

SONUGÜR F. G.
in: Gene Therapy Principles and Challenges, Hashad Doaa, Editor, IntechOpen, Londrina, pp.1-36, 2015
Metrics

Publication

32

Publication (WoS)

13

Publication (Scopus)

11

Citation (WoS)

123

H-Index (WoS)

3

Citation (Scopus)

66

H-Index (Scopus)

2

Citation (Scholar)

130

H-Index (Scholar)

3

Citation (Sum Other)

3

Project

4

Open Access

2
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING